Engage2Serve, Inc. Launches Seamless Student Lifecycle CRM for Higher Education

Jun 27, 2017 11:39 am UTC| Business

AUSTIN, Texas, June 27, 2017 -- Engage2Serve, Inc., a global provider of higher education solutions, has recently launched its Engage2Serve (“e2s”) lifecycle product suite to aid student recruitment, retention, and...

Cancer Genetics, Inc. Launches FDA-Approved Universal Companion Diagnostic for Lung Cancer Leveraging Thermo Fisher's Next Generation Sequencing Panel Oncomine Dx Target Test

Jun 27, 2017 11:35 am UTC| Business

CGI is one of the first laboratories in the nation to offer the 23 gene testCGI is working with both pharmaceutical partners and clinical cancer centers to drive usage and adoptionEliminates need for multiple tests to...

Mandalay Resources Corporation Provides Update on Work at Cerro Bayo Mine

Jun 27, 2017 11:30 am UTC| Business

TORONTO, June 27, 2017 -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX:MND) regretfully announces that efforts to search for and locate the two Mandalay employees working in the flooded Delia NW...

Pacific Ethanol to Acquire Illinois Corn Processing

Jun 27, 2017 11:30 am UTC| Business

SACRAMENTO, Calif., June 27, 2017 -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels in the United States, entered into a definitive agreement to acquire Illinois Corn...

Trek Mining Continues to Intersect Significant Gold Mineralization at Piaba West

Jun 27, 2017 11:30 am UTC| Business

VANCOUVER, British Columbia, June 27, 2017 -- Trek Mining Inc. (TSX-V:TREK) (“Trek Mining” or “the Company”) is pleased to announce that ongoing drilling continues to intersect significant gold mineralization below the...

Strongbridge Biopharma plc Completes Target Enrollment of 90 Patients in the Phase 3 SONICS Study Evaluating RECORLEV™ (levoketoconazole) in Endogenous Cushing’s Syndrome

Jun 27, 2017 11:30 am UTC| Business

DUBLIN, Ireland and TREVOSE, Pa., June 27, 2017 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...

Marinus Pharmaceuticals Launches the Ganaxolone Clinical Program in Patients with Postpartum Depression

Jun 27, 2017 11:30 am UTC| Business

Program to Evaluate Intravenous and Oral Ganaxolone in Patients with Severe or Moderate Postpartum Depression RADNOR, Pa., June 27, 2017 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company...